160
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers

, , , , , , & show all
Pages 181-191 | Received 01 Jul 2010, Accepted 23 Nov 2010, Published online: 14 Jan 2011

References

  • Aebersold R, Mann M. (2003). Mass spectrometry-based proteomics. Nature 422:198–207.
  • Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, Selby PJ. (2005). Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 51:1637–1649.
  • Breiman L, Friedman JH, Olshen RA, Stone CJ. (1984). Classification and Regression Trees. New York: Chapman & Hall.
  • Cappello F, Di Stefano A, D’Anna SE, Donner CF, Zummo G. (2005). Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol 6:816.
  • Cardoso CM, Groth-Pedersen L, Høyer-Hansen M, Kirkegaard T, Corcelle E, Andersen JS, Jäättelä M, Nylandsted J. (2009). Depletion of kinesin 5B affects lysosomal distribution and stability and induces peri-nuclear accumulation of autophagosomes in cancer cells. PLoS ONE 4:e4424.
  • Diamandis EP. (2004). Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96:353–356.
  • Ebbing B, Mann K, Starosta A, Jaud J, Schöls L, Schüle R, Woehlke G. (2008). Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet 17:1245–1252.
  • Gillette MA, Mani DR, Carr SA. (2005). Place of pattern in proteomic biomarker discovery. J Proteome Res 4:1143–1154.
  • Hesterberg TW, Barrett JC. (1985). Induction by asbestos fibers of anaphase abnormalities: mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis 6:473–475.
  • Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, Packham J, Worthington J, Thomson W; Childhood Arthritis Prospective Study (CAPS); UKRAG Consortium; BSPAR Study Group. (2009). Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 69:1049–1053.
  • Husgafvel-Pursiainen K, Kannio A, Oksa P, Suitiala T, Koskinen H, Partanen R, Hemminki K, Smith S, Rosenstock-Leibu R, Brandt-Rauf PW. (1997). Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ Mol Mutagen 30:224–230.
  • Huszar D, Theoclitou ME, Skolnik J, Herbst R. (2009). Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 28:197–208.
  • Koomen JM, Shih LN, Coombes KR, Li D, Xiao LC, Fidler IJ, Abbruzzese JL, Kobayashi R. (2005). Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 11:1110–1118.
  • Lea JS, Coleman R, Kurien A, Schorge JO, Miller DS, Minna JD, Muller CY. (2004). Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol 190:674–679.
  • Li L, Sun TD, Zhang X, Lai RN, Li XY, Fan XJ, Morinaga K. (2004). Cohort studies on cancer mortality among workers exposed only to chrysotile asbestos: a meta-analysis. Biomed Environ Sci 17:459–468.
  • Li Y, Begovich AB. (2009). Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol 21:318–327.
  • MacCorkle RA, Slattery SD, Nash DR, Brinkley BR. (2006). Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts. Cell Motil Cytoskeleton 63:646–657.
  • Marshall J, Kupchak P, Zhu W, Yantha J, Vrees T, Furesz S, Jacks K, Smith C, Kireeva I, Zhang R, Takahashi M, Stanton E, Jackowski G. (2003). Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res 2:361–372.
  • Mayr MI, Hümmer S, Bormann J, Grüner T, Adio S, Woehlke G, Mayer TU. (2007). The human kinesin Kif18A is a motile microtubule depolymerase essential for chromosome congression. Curr Biol 17:488–498.
  • Miki H, Okada Y, Hirokawa N. (2005). Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 15:467–476.
  • Mori H, Yamada Y, Hirose Y, Kuno T, Katayama M, Sakata K, Yoshida K, Sugie S, Hara A, Yoshimi N. (2002). Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker. Eur J Cancer Prev 11 (Suppl 2):S71–S75.
  • Oksa P, Pukkala E, Karjalainen A, Ojajärvi A, Huuskonen MS. (1997). Cancer incidence and mortality among Finnish asbestos sprayers and in asbestosis and silicosis patients. Am J Ind Med 31:693–698.
  • Pappin DJ, Hojrup P, Bleasby AJ. (1993). Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3:327–332.
  • Reid A, de Klerk N, Ambrosini GL, Olsen N, Pang SC, Berry G, Musk AW. (2005). The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med 62:885–889.
  • Rogers MA, Clarke P, Noble J, Munro NP, Paul A, Selby PJ, Banks RE. (2003). Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 63:6971–6983.
  • Schägger H. (2006). Tricine-SDS-PAGE. Nat Protoc 1:16–22.
  • Shamma A, Doki Y, Shiozaki H, Tsujinaka T, Yamamoto M, Inoue M, Yano M, Monden M. (2000). Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. Int J Oncol 16:261–266.
  • Stumpff J, von Dassow G, Wagenbach M, Asbury C, Wordeman L. (2008). The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment. Dev Cell 14:252–262.
  • Teppo L, Pukkala E, Lehtonen M. (1994). Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33:365–369.
  • Villar-Garea A, Griese M, Imhof A. (2007). Biomarker discovery from body fluids using mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 849:105–114.
  • Winer I, Normolle DP, Shureiqi I, Sondak VK, Johnson T, Su L, Brenner DE. (2002). Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Melanoma Res 12:429–434.
  • Zhu C, Zhao J, Bibikova M, Leverson JD, Bossy-Wetzel E, Fan JB, Abraham RT, Jiang W. (2005). Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell 16:3187–3199.
  • Zolg JW, Langen H. (2004). How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 3:345–354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.